Back to Bills
HOUSE-BILL 7482119th Congress

H.R.7482 - LymeX Authorization Act

Introduced: February 11, 2026
Status: Introduced
supported

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 7482 aims to enhance the prevention, diagnosis, and treatment of Lyme disease, directly benefiting individuals affected by this condition and their families. The legislation addresses major themes such as healthcare access, public health innovation, and stakeholder engagement, emphasizing the importance of patient-centered care. Key provisions include the authorization of $5 million for prize competitions to accelerate innovations in Lyme disease treatment and diagnostics, as well as initiatives to improve public awareness and education about the disease. Implementation will require collaboration among various stakeholders, including academia and industry, to ensure effective outcomes. Potential impacts include improved healthcare access and outcomes for Lyme disease patients, although there are constitutional concerns regarding federal funding allocations and equitable access to new treatments across different socioeconomic groups.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill aims to enhance healthcare outcomes for individuals affected by Lyme disease through funding for innovative treatments and diagnostics. This aligns with the government's responsibility to promote public health, which is a recognized constitutional interest.

Key Individual Rights

Positive

  • Right to Health Care (implied)
  • Equal Protection (14th Amendment)

Negative

  • Potential disparities in access to healthcare innovations

Constitutional Provisions

  • 14th Amendment - Equal Protection Clause
  • Spending Power

Potential Constitutional Challenges

The bill may face challenges if it is perceived to disproportionately benefit certain demographic groups over others, potentially violating the Equal Protection Clause. Ensuring equitable access to innovations funded by the bill will be crucial to avoid discrimination.

Summary

HOUSE-BILL 7482 has the potential to significantly benefit individuals suffering from Lyme disease by improving access to innovative healthcare solutions. However, it is essential to monitor the implementation of the bill to ensure that it does not exacerbate existing health disparities among different demographic groups, particularly those who are marginalized or have limited access to healthcare.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 7482 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Timeline

February 11, 2026

Bill Introduced

Current

Introduced

March 17, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat